BG
AGN

Bahl & Gaynor’s Allergan plc AGN Stock Holding History

Bahl & Gaynor’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,005
Closed -$244K – 407
2017
Q2 		$244K Buy
+1,005
New +$236K ﹤0.01% 390
2016
Q2 		– Sell
-1,717
Closed -$460K – 412
2016
Q1 		$460K Sell
1,717
-200
-10% -$57.3K 0.01% 317
2015
Q4 		$599K Sell
1,917
-254
-12% -$75.6K 0.01% 283
2015
Q3 		$590K Sell
2,171
-414
-16% -$127K 0.01% 294
2015
Q2 		$784K Buy
2,585
+1,376
+114% +$410K 0.01% 259
2015
Q1 		$360K Buy
+1,209
New +$345K ﹤0.01% 350

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Bahl & Gaynor's AGN Position: Q3 2017 in Review

Bahl & Gaynor sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,005 shares — an estimated $244K sold.

Bahl & Gaynor first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $784K in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Bahl & Gaynor reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Bahl & Gaynor sold 1,005 Allergan plc shares in Q3 2017, an estimated $244K.
  • Bahl & Gaynor first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Bahl & Gaynor's Allergan plc position peaked at $784K in Q2 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Bahl & Gaynor's 13F filing for Q3 2017, filed 13 Nov 2017.